Xylanase Expression in Pichia methanolica via Gene Optimization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The demand for xylanase from anaerobic fungi is hindered by limitations in culture techniques and slow growth rates, making large-scale production challenging, and existing methods for recombinant protein production in yeasts do not meet industrial or academic demands for high activity and thermo-tolerant xylanases.
Innovation Solution
A modified nucleotide molecule encoding xylanase with a sequence homology of at least 80% to a specific sequence is used, combined with a secreting protein signal peptide, and expressed in a Pichia methanolica host cell through gene optimization and transformation, enhancing expression efficiency and thermo-stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If natural cultivation method is used for anaerobic fungi, then xylanase can be produced, but production scale is limited due to slow growth rate and culture technique limitations
Solution Approach 1:
The patent copies the xylanase production capability from anaerobic fungi to a yeast host cell through gene cloning. The xylanase gene is isolated from anaerobic fungi and inserted into yeast cells, which then produce xylanase without requiring the slow-growing fungal culture. This copying approach transfers the desired function to a faster-growing organism, resolving the contradiction between production scale and growth time.
Solution Approach 2:
The patent modifies the expression parameters of the xylanase gene by optimizing codon usage to match the host yeast's preferences and by adjusting promoter strength and cultivation conditions. These parameter changes enable high-level expression of xylanase in yeast, achieving industrial-scale production without being constrained by the original fungal growth rate.
2Productivity
If existing recombinant protein production methods in yeasts are used, then xylanase can be expressed, but expression levels are insufficient for industrial or academic demands
Solution Approach 1:
The patent systematically optimizes multiple parameters of the xylanase gene including codon usage frequency, GC content, promoter strength, and signal peptide sequences to match the yeast host's preferences. These parameter changes collectively enhance transcription and translation efficiency, achieving high-level expression that meets industrial demands while providing a systematic approach that can be applied to other recombinant protein productions.
Solution Approach 2:
The patent employs iterative optimization where expression levels are measured and used to guide further gene modifications. By monitoring expression outcomes and adjusting gene parameters accordingly, the method achieves progressively higher expression levels, transforming the manufacturing process from trial-and-error to a directed optimization approach.
3Reliability
If xylanase from anaerobic fungi is produced, then high enzymatic activity and thermo-tolerance are achieved, but mass production is hindered by culture limitations
Solution Approach 1:
The patent copies not only the xylanase gene but also the desirable functional characteristics (high enzymatic activity and thermo-tolerance) from anaerobic fungi to yeast cells. The recombinant yeast expresses xylanase with properties identical to or superior to the original fungal enzyme, while overcoming the cultural limitations that prevented mass production. This copying enables reliable production of high-performance enzyme at industrial scale.
Data Source
AI summary
Modified nucleotide molecules of xylanase and the application of the nucleotide molecules in constructing recombinant vectors, host cells or producing xylanase are disclosed, wherein the nucleotide molecules contain nucleotide sequences having greater than 80% identity with nucleotide sequence shown by SEQ ID NO: 1.